Sultiame pharmacokinetic profile in plasma and erythrocytes after single oral doses: A pilot study in healthy volunteers-Reference-Cited by-同舟云学术

Sultiame pharmacokinetic profile in plasma and erythrocytes after single oral doses: A pilot study in healthy volunteers

Published:2020-01-28 Issue:1 Volume:8 Page:
ISSN:2052-1707
Container-title:Pharmacology Research & Perspectives
language:en
Short-container-title:Pharmacol Res Perspect

Author:

Dao Kim¹^ORCID,Thoueille Paul¹,Decosterd Laurent A.¹,Mercier Thomas¹,Guidi Monia¹²,Bardinet Carine¹,Lebon Sébastien³,Choong Eva¹,Castang Arnaud⁴,Guittet Catherine⁴,Granier Luc‐André⁴,Buclin Thierry¹^ORCID

Affiliation:

1. Service of Clinical Pharmacology Lausanne University HospitalUniversity of Lausanne Lausanne Switzerland

2. School of Pharmaceutical Sciences Institute of Pharmaceutical Sciences of western Switzerland Geneva Switzerland

3. Unit of Paediatric Neurology and Neurorehabilitation Department Mother‐Woman‐Child Lausanne University HospitalUniversity of Lausanne Lausanne Switzerland

4. Advicenne Pharma SA Nîmes France

Funder

Advicenne Pharma

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/prp2.558

Reference19 articles.

1. Carbonic Anhydrase Inhibitor Sulthiame Reduces Intracellular pH and Epileptiform Activity of Hippocampal CA3 Neurons

2. Effects of Levetiracetam and Sulthiame on EEG in benign epilepsy with centrotemporal spikes: A randomized controlled trial